| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81075-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52675-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26212-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26618-50ul | |||
![In vitro assay: Recombinant Human alpha-Synuclein Active, Monomer, (Type 1) Acetyl (N-Term) Protein [NBP3-14768] - Thioflavin T assay for N-terminal acetylated alpha synuclein monomers (NBP3-14768) and pre-formed fibrils (PFFs) . Increased fluorescence, indicative of beta-sheet formation, was seen when 50 ug N-acetylated monomer and 5 ug N-acetylated fibril were combined, compared to monomer or fibril alone.](http://images.novusbio.com/fullsize/Recombinant-Human-alpha-Synuclein-Active-Monomer-Type-1-Acetyl-N-Term-Protein-In-vitro-assay-NBP3-14768-img0001.jpg "In vitro assay: Recombinant Human alpha-Synuclein Active, Monomer, (Type 1) Acetyl (N-Term) Protein [NBP3-14768] - Thioflavin T assay for N-terminal acetylated alpha synuclein monomers (NBP3-14768) and pre-formed fibrils (PFFs) . Increased fluorescence, indicative of beta-sheet formation, was seen when 50 ug N-acetylated monomer and 5 ug N-acetylated fibril were combined, compared to monomer or fibril alone.")
![Western Blot: CENPJ Antibody [NBP1-50018] - Whole cell lysate (5, 15 and 50 ug) from HeLa cells. Antibody used at 0.04 ug/ml.](http://images.novusbio.com/fullsize/CENPJ-Antibody-Western-Blot-NBP1-50018-img0002.jpg "Western Blot: CENPJ Antibody [NBP1-50018] - Whole cell lysate (5, 15 and 50 ug) from HeLa cells. Antibody used at 0.04 ug/ml.")
![Immunohistochemistry: Huntingtin Antibody (6F2) [NBP3-26212] - Image of Huntingtin Antibody (6F2) diluted at 1:100 and staining in paraffin-embedded human small intestine tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26212_rabbit-huntingtin-mab-6f2-262202415355726.jpg "Immunohistochemistry: Huntingtin Antibody (6F2) [NBP3-26212] - Image of Huntingtin Antibody (6F2) diluted at 1:100 and staining in paraffin-embedded human small intestine tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.")
![Immunohistochemistry: Huntingtin Antibody (6F2) [NBP3-26212] - Image of Huntingtin Antibody (6F2) diluted at 1:100 and staining in paraffin-embedded human small intestine tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26212_rabbit-huntingtin-mab-6f2-2722024827494.jpg)
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272346.jpg "ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.")
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.102-1.707 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272316.jpg)
![Flow Cytometry: DLL3 Antibody (7B7) [NBP3-26618] - Untransfected HEK293 cells (green line) and transfected Human DLL3 HEK293 stable cells (red line) were stained with anti-DLL3 antibody (rovalpituzumab-like) (2ul/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG1 Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-282202414312733.jpg)